Warning labels on Mounjaro, Ozempic, and a whole host of other similar type 2 diabetes drugs list gastrointestinal problems, such as the following, as potential side effects associated with them: Abdominal discomfort or pain Nausea Bloating Vomiting Constipation Discolored stools Indigestion Diarrhea However, in entering Ozempic, Mounjaro, and other similar medications into the FDA Adverse Events Reporting System (FAERS) Public Dashboard, thousands of reports of much more serious adverse side effects, including the following, come up: Pancreatitis Gallbladder issues Kidney failure Thyroid tumors Cancer Gastroparesis Gastroparesis, also known as stomach paralysis, is what has led to many patients filing lawsuits against the drugs manufacturers most recently
If the exposure was severe, discard it without hesitation
These tablets are white to light yellow, oval-shaped, and film-coated
In addition, for insured patients, CVS Caremark, the nations largest pharmacy benefit manager, said that starting in July, the weight loss treatments Wegovy and Saxenda (liraglutide) will be the preferred GLP-1 medicines on its largest commercial formularies, which usually means fewer access restrictions such as prior authorization, but also lower patient cost-sharing
